Single Midlife PSA Test May Identity Long-Term Prostate Cancer Risk

(MedPage Today) — A low baseline prostate-specific antigen (PSA) level in midlife was associated with a reduced long-term risk of prostate cancer, according to a German cohort study.
Among the 1,482 men with serum PSA levels less than 1.00 ng…